Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol ENO1 contributors: mct - updated : 06-12-2011
HGNC name enolase 1, (alpha)
HGNC id 3350
EXPRESSION
Type ubiquitous
   expressed in (based on citations)
organ(s)
SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
Visualeyelens   
 eyeanterior segmentcornea  
tissue
SystemTissueTissue level 1Tissue level 2LevelPubmedSpeciesStageRna symbol
Connective    
cell lineage
cell lines
fluid/secretion
at STAGE
physiological period embryo, pregnancy
Text precocious type
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
HOMOLOGY
Homologene
FAMILY
CATEGORY enzyme , structural protein , antigen , tumor suppressor
SUBCELLULAR LOCALIZATION     plasma membrane
    intracellular
intracellular,cytoplasm,cytosolic
intracellular,nucleus
text
  • nuclear form found in almost all the normal tissues while its expression was retained in only 35p100 of the tumors
  • basic FUNCTION
  • glycolysis, energy pathway converting 2 phospho-D-glycerate to phosphoenol-pyruvate tau-crystallin with reduced enolase activity
  • regulating MYC expression
  • has tumour suppressor activity and high level of ENO1 expression has growth inhibitory effects
  • activated NOTCH1 receptor and ENO1 cooperate in controlling MYC expression through binding the YY1 response element of the MYC promoter to regulate tumorigenesis
  • its structure exhibits distinct surface properties, explaining its various activities, including plasmin(ogen) and DNA binding
  • ENO1-mediated promotion of cell transformation and invasion partly via induced CCL20 expression
  • glycolytic enzyme that catalyses the formation of phosphoenolpyruvate in the cell cytoplasm
  • functions in repressing MYC gene expression and the loss of nuclear ENO1 expression in a large number of invasive ductal breast carcinoma may be a critical step in the development and progression of breast cancer
  • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling
    a component
    INTERACTION
    DNA
    RNA
    small molecule
    protein
  • TRAPPC2 interaction with the transcription factors ENO1, PITX1 and SF1
  • binds to the P2 c-myc promoter and competes with TATA-box binding protein (TBP) to suppress gene transcription
  • cell & other
    REGULATION
    ASSOCIATED DISORDERS
    corresponding disease(s)
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    tumoral     --over  
    overexpressed in lymphocytic hypophysitis and other autoimmune disease, and in gastric cancer
    tumoral     --over  
    prognostic role of ENO1 overexpression in head and neck cancer
    Susceptibility
    Variant & Polymorphism
    Candidate gene
    Marker
  • nuclear ENO1 appears to be a novel and valuable histochemical marker with potential prognostic value in breast cancer
  • Therapy target
    SystemTypeDisorderPubmed
    cancerdigestivestomach
    MBP-1-suppressed COX2 expression plays an important role in the inhibition of growth and progression of gastric cancer
    ANIMAL & CELL MODELS